Page last updated: 2024-11-01

ondansetron and Pancreatitis

ondansetron has been researched along with Pancreatitis in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberti-Flor, JJ1
Granados, LM1
Ballester, F1
Suárez, F1
Sánchez-Peña, J1
Navas, E1

Other Studies

2 other studies available for ondansetron and Pancreatitis

ArticleYear
Pancreatitis associated with ondansetron.
    Journal of the National Cancer Institute, 1995, May-03, Volume: 87, Issue:9

    Topics: Humans; Male; Middle Aged; Ondansetron; Pancreatitis

1995
[Acute postoperative pancreatitis, is it associated with the use of ondansetron?].
    Revista espanola de anestesiologia y reanimacion, 1997, Volume: 44, Issue:2

    Topics: Acute Disease; Adolescent; Antiemetics; Humans; Nasal Bone; Ondansetron; Pancreatitis; Postoperative

1997